KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
KRAS突变可预测接受一线贝伐珠单抗和铂类化疗的晚期肺腺癌患者的疗效和预后
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers11101514
Ghimessy, Aron Kristof; Gellert, Aron; Schlegl, Erzsebet; Hegedus, Balazs; Raso, Erzsebet; Barbai, Tamas; Timar, Jozsef; Ostoros, Gyula; Megyesfalvi, Zsolt; Gieszer, Balazs; Moldvay, Judit; Renyi-Vamos, Ferenc; Lohinai, Zoltan; Hoda, Mir Alireza; Klikovits, Thomas; Klepetko, Walter; Laszlo, Viktoria; Dome, Balazs